MUTARS Humerus Cap - Humeral head prosthesis

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Disponible depuis:

Life Healthcare Pty Ltd

classe:

Class III

Fabriqué par:

Implantcast GmbH Luneburger Schanze 26, Buxtehude, 21614 Germany

Domaine thérapeutique:

48088 - Humeral head prosthesis

indications thérapeutiques:

Constructed of TiAl6V4 with TiN coating. The modular humerus caps are available in three different sizes and allow an optimal glenoid contact. Connects to a humerus head component as part of the Modular Universal Tumor and Revision System (MUTARS) and articulates with the glenoid. Humerus cap component of the MUTARS system used as part of a humeral replacement. Primary indication for the use of the MUTARS systems is after bone resection because of a tumour. Further indications for the use of the MUTARS systems are massive bone loss such as in Morbus Gorham or for the revision arthroplasty and for the prosthetic treatment in case of fractures, pseudarthrosis and arthrosis.

Statut de autorisation:

A

Date de l'autorisation:

2014-09-10